Skip to main content

Table 1 Characteristics of the embryos from PGT-A cycles with three COS protocols

From: Correlation between controlled ovarian stimulation protocols and euploid blastocyst rate in pre-implantation genetic testing for aneuploidy cycles

 

PPOS protocol

GnRH-a protocol

GnRH-ant protocol

P value

Cycles (n)

152

126

179

 

Female age(y)

37.11 ± 4.48 a

33.82 ± 5.25 b

34.01 ± 4.88 b

< 0.001

Female BMI (kg/m2)

22.33 ± 2.65

22.04 ± 2.63

21.97 ± 2.77

0.453

Male age(y)

39.72 ± 6.11a

35.98 ± 6.48 b

36.48 ± 6.59 b

< 0.001

Infertility type

   

0.899

Primary (n/%)

30 (19.7%)

25 (19.8%)

32 (17.9%)

 

Secondary (n/%)

122 (80.3%)

101 (80.2%)

147 (82.1%)

 

Infertility duration (y)

3.32 ± 3.38

2.98 ± 3.14

3.04 ± 3.04

0.643

bFSH (IU/L)

8.15 ± 2.96 a

6.83 ± 2.19 b

6.96 ± 1.85 b

< 0.001

AMH (ng/ml)

2.27 ± 2.33 a

3.16 ± 2.08 b

3.62 ± 2.37 b

< 0.001

AFC

10.03 ± 6.72 a

11.76 ± 4.63 b

12.87 ± 6.30 b

< 0.001

Gn days (d)

8.93 ± 2.00 b

10.95 ± 2.00 a

9.17 ± 1.45 b

< 0.001

Gn dosage (IU)

2090.30 ± 650.09 b

2589.83 ± 821.74 a

2024.59 ± 531.60 b

< 0.001

E2 on trigger day (pg/ml)

2400.83 ± 1532.08 a

3485.49 ± 2017.96 b

3073.83 ± 1689.18 b

< 0.001

LH on trigger day (IU/L)

3.52 ± 2.39 a

1.93 ± 1.33 b

3.18 ± 2.32 b

< 0.001

  1. BMI, body mass index; bFSH, basal follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; AMH, anti-Müllerian hormone; Gn, gonadotropin
  2. a.b means significant differences between the two groups